Informasjon, tilstand

Cystisk fibrose

Cystisk fibrose er en arvelig sykdom med forstyrrelser i kjertelfunksjonen i flere organ. Det er særlig symptomer fra lungene og magetarmkanalen som dominerer sykdomsbildet.

Sist revidert: 19.08.2021

Hva er cystisk fibrose?

Cystisk fibrose er en arvelig sykdom med forstyrrelser i kjertelfunksjonen i flere organ, blant annet lunger, magetarmkanal og bukspyttkjertelen. Sykdommen fører til dannelse av et unormalt seigt slim som tetter igjen kjertler og utførselsganger spesielt i lunger, bihuler, bukspyttkjertel og mannlige kjønnsorgan.

Tilstanden er karakterisert ved

svekket lungefunksjon og kronisk bakterielle infeksjoner i luftveier og bihuler
redusert nedbrytning og opptak av fett og proteiner som følge av svikt i bukspyttkjertelen
nedsatt fruktbarhet (infertilitet) hos menn på grunn av blokkering av sædlederen
økt konsentrasjon av klor i svette

Vil du vite mer?

Få tilgang på artikkelen om dette temaet fra Legehandboka.no

Artikkelen inneholder all informasjon norske allmennleger bruker i sitt daglige arbeid.

Jeg har lest og akseptert Brukervilkår ved kjøp av NEL-dokumenter

Dette dokumentet er basert på det profesjonelle dokumentet "Cystisk fibrose". Referanselisten for dette dokumentet vises nedenfor.

Elborn JS. Cystic fibrosis. Lancet 2016; 388:2519. PubMed
Shteinberg M, Haq IJ, Polineni D, Davies JC. Cystic fibrosis. Lancet. 2021;397(10290):2195-2211. PMID: 34090606.
Bobadilla JL, Macek M Jr, Fine JP, et al. Cystic fibrosis: a worldwide analysis of CFTR mutations - correlation with incidence data and application to screening. Hum Mutat 2002; 19: 575-606. PubMed
Yankaskas JR, Marshall BC, Sufian B, et al. Cystic fibrosis adult care: consensus conference report. Chest 2004; 125(suppl): 1-39.
Katkin JP. Cystic fibrosis: Clinical mamnnifestations and diagnosis. UpToDate, last updated Aug 20, 2020. UpToDate
Dorlöchter L, Røksund OD, Fluge G, Rosendahl K. Høyoppløsningscomputertomografi av lungene ved cystisk fibrose. Tidsskr Nor Lægeforen 2002; 122: 1549-51. PubMed
Grosse SD, Rosenfeld M, Devine OJ, Lai HJ, Farrell PM. Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. J Pediatr 2006; 149: 362-6. PubMed
De Boeck K, Wilschanski M, Castellani C, et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 2006; 61: 627-35. PubMed
Desax MC, Ammann RA, Hammer J, et al. Nanoduct(R) sweat testing for rapid diagnosis in newborns, infants and children with cystic fibrosis. Eur J Pediatr 2007, April 14. Epub ahead of print.
Murphy MP, Caraher E. Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its Symptoms. Drugs R D. 2016 Mar;16(1):1-17. pmid: 26747453. PubMed
Ratjen F, Davis SD, Stanojevic S, et al. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2019 Sep;7(9):802-9. PubMed
Flume PA, O'Sullivan BP, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007; 176: 957-69. PubMed
Radtke T, Nevitt SJ, Hebestreit H, Kriemler S. Physical exercise training for cystic fibrosis. Cochrane Database of Systematic Reviews 2017, Issue 11. Art. No.: CD002768. DOI: 10.1002/14651858.CD002768.pub4. DOI
Jagannath VA, Fedorowicz Z, Thaker V, Chang AB. Vitamin K supplementation for cystic fibrosis. Cochrane Database Syst Rev. 2015 Jan 18;1:CD008482. doi: 10.1002/14651858.CD008482.pub4. DOI
Lai HJ. Classification of nutritional status in cystic fibrosis. Curr Opin Pulm Med 2006; 12: 422-7. PubMed
Burton CM, Milman N, Carlsen J, Arendrup H, Eliasen K, Andersen CB, et al. The Copenhagen National Lung Transplant Group: survival after single lung, double lung, and heart-lung transplantation. J Heart Lung Transplant 2005; 24: 1834-43. PubMed
Ciofu O, Lykkesfeldt J. Antioxidant supplementation for lung disease in cystic fibrosis. Cochrane Database Syst Rev. 2014 ;8:CD007020. doi: 10.1002/14651858.CD007020.pub3. The Cochrane Library
Patel S, Sinha IP, Dwan K, Echevarria C, Schechter M, Southern KW. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD009841. DOI: 10.1002/14651858.CD009841.pub2 DOI
Wainwright CE, Elborn JS, Ramsey BW, et al. Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR. N Engl J Med 2015. doi:10.1056/NEJMoa1409547 DOI
Middleton PG, Mall MA, Dřevínek P, et al. Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with a single Phe508del allele. N Engl J Med 2019; 381: 1809-19 2019. doi: 10.1056/NEJMoa1908639 DOI
Heijerman HGM, KcKone EF, Downey DG, et al. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: A double-blind, randomised, phase 3 trial. Lancet 2019. pmid: 31679946 PubMed
Lee TWR, Southern KW. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease. Cochrane Database of Systematic Reviews 2013; 11: CD005599. doi:10.1002/14651858.CD005599.pub4 DOI
Alton EWFW, Armstrong DK, Ashby D, et al. Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phasse 2b trial. Lancet Respir Med 2015. doi:10.1016/S2213-2600(15)00245-3 DOI
Flume PA, O'Sullivan BP, Robinson KA, et al, and the Cystic Fibrosis Foundation, Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007; 176: 957-69. PubMed
Balaguer A, González de Dios J. Home versus hospital intravenous antibiotic therapy for cystic fibrosis. Cochrane Database of Systematic Reviews 2015, Issue 12. Art. No.: CD001917. DOI: 10.1002/14651858.CD001917.pub4. DOI
Balfour-Lynn IM, Welch K. Inhaled corticosteroids for cystic fibrosis. Cochrane Database Syst Rev. 2014 ;10:CD001915. PMID: 25300165. PubMed
Mogayzel PJ Jr, Naureckas ET, Robinson KA, et al. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013 Apr 1;187(7):680-9. PubMed
Elkins MR, Robinson M, Rose BR, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006; 354: 229-40. PubMed
Wark P, McDonald VM. Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst Rev 2009; 15: CD001506. Cochrane (DOI)
Deterding RR, Lavange LM, Engels JM, et al. Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis. Am J Respir Crit Care Med 2007; 176: 362-9. PubMed
Accurso FJ, Schaberg A, Durham T, et al. Pulmonary function decline over one year in cystic fibrosis patients: An exploratory analysis of the phase 3 (TIGER-1) trial of aerosolized denufosol. Am J Resp Crit Care 2011.
Liang J, Higgins T, Ishman SL, et al. Medical management of chronic rhinosinusitis in cystic fibrosis: a systematic review. Laryngoscope. 2014 ;124(6):1308-13. PMID: 24338982 PubMed
McArdle JR, Talwalkar JS. Macrolides in cystic fibrosis. Clin Chest Med 2007; 28: 347-60. PubMed
Lands LC, Stanojevic S. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. Cochrane Database Syst Rev. 2019 Sep 9;(9):CD001505. Cochrane (DOI)
Warnock L, Gates A. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. Cochrane Database of Systematic Reviews 2015, Issue 12. Art. No.: CD001401. DOI: 10.1002/14651858.CD001401.pub3. DOI
Liou TG, Adler FR, Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005; 171: 1053-9. PubMed
Liou TG, Adler FR, Cox DR, and Cahill BC. Lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2007; 357: 2143-52. PubMed
Allen J, Visner G. Lung transplantation in cystic fibrosis - primum non nocere?. N Engl J Med 2007; 357: 2186-8. PubMed
Conway SP, Morton A, Wolfe S. Enteral tube feeding for cystic fibrosis. The Cochrane Collaboration, 12 May 2010. CD001198.pub2. Cochrane (DOI)
Sarles J, Berthezene P, Le Louarn C, et al. Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis. J Pediatr 2005; 147: 302-5. PubMed
Hnin K, Nguyen C, Carson KV, et al. Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults. Cochrane Database of Syst Rev 2015, Issue 8. Art. No.: CD001392. DOI: 10.1002/14651858.CD001392.pub3. DOI
Johansen HK, Gotzsche PC. Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis. Cochrane Database Syst Rev 2013; 6: CD001399. doi:10.1002/14651858.CD001399.pub3 DOI
McMullen AH, Pasta DJ, Frederick PD, et al. Impact of pregnancy on women with cystic fibrosis. Chest 2006; 129: 706-11. PubMed
Boyle MP. Update on maintaining bone health in cystic fibrosis. Curr Opin Pulm Med 2006; 12: 453-8. PubMed
George PM, Banya W, Pareek N, et al. Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007. BMJ 2011; 342: d1008. BMJ (DOI)
MacKenzie T, Gifford AH, Sabadosa KH, et al. Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: Survival analysis of the cystic fibrosis foundation patient registry . Ann Intern Med 2014; 161: 233-41. doi:10.7326/M13-0636 DOI

Er du helsepersonell?

Ved å oppgi dette kan du få bedre tilpasset innhold om du har formell helsefaglig kompetanse

Mest lest i dag

Å leve med

Cystisk fibrose

Hopp til innhold

Hva er cystisk fibrose?

Er du helsepersonell?

Mest lest i dag

Å leve med Sjøgrens syndrom

Symptomer på infeksjon med coronavirus

Skarlagensfeber

Informasjon

Hold deg oppdatert

Cystisk fibrose

Hopp til innhold

Hva er cystisk fibrose?

Er du helsepersonell?

Andre leste også dette

Cystisk fibrose

Kostholdsråd for pasienter med cystisk fibrose

Å leve med cystisk fibrose

Mest lest i dag

Å leve med Sjøgrens syndrom

Symptomer på infeksjon med coronavirus

Skarlagensfeber